MDX-210 bispecific humanized antibody targeted to HER-2 protein on cancer cells and to receptors on white blood cells: Filed IND for a trial in up to 30 patient

Medarex Inc. (MEDX), Annandale, N.J. Product: MDX-210 bispecific humanized antibody targeted to HER-2 protein on cancer cells and to receptors on white blood cells Indication: Prostate cancer that ha...